# A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes

Study · id `cardio:ct-nct02606617` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02606617](<https://clinicaltrials.gov/study/NCT02606617>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02606617

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02606617. Randomized; quadruple masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02606617, source copy `cardio:ctgov-nct02606617-2015-11-17`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02606617, source copy `cardio:ctgov-nct02606617-2015-11-17`, retrieved 2026-10-26)
- Primary completion: 2016-09 (anticipated) (ClinicalTrials.gov record NCT02606617, source copy `cardio:ctgov-nct02606617-2015-11-17`, retrieved 2026-10-26)
- Completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02606617, source copy `cardio:ctgov-nct02606617-2015-11-17`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02606617-2015-11-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Drug): Mosapride
- Intervention (Drug): Placebo
- Lead sponsor: Third Military Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Third Military Medical University (`cardio:org-third-military-medical-university`)

## Provenance

Content hash: a1d8e322109f42527f9e21b3dbac7c68028b62dc8ab459a8d17a5025443423b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
